Reduced oral etoposide bioavailability in patients with advanced cancer of the head and neck.
Desoize
B
B
Laboratoire de Pharmacologie, Institut Jean-Godinot, Reims, France.
Woirin
V
V
Legros
M
M
Coninx
P
P
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000150:complications; D001682:Biological Availability; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D005047:Etoposide / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006258:Head and Neck Neoplasms / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged
D005047:Etoposide